CLASSIC HODGKIN LYMPHOMA
Clinical trials for CLASSIC HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSIC HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSIC HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test may allow safer, tailored chemo for hodgkin lymphoma patients
Disease control Recruiting nowThis study is for people with advanced Hodgkin lymphoma. It tests whether a blood test that measures tumor DNA can help doctors safely give fewer chemotherapy treatments. Participants will receive a combination of drugs, and the number of cycles will be personalized based on thei…
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
New hope for advanced hodgkin lymphoma: drug combo trial launches
Disease control Recruiting nowThis study tests whether adding pianzumab to standard chemotherapy (AVD) helps more people with newly-diagnosed advanced classic Hodgkin lymphoma achieve remission. About 108 adults with stage III-IV or high-risk stage IIB disease will participate. The goal is to see if the combi…
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
New hope for frail hodgkin patients: immunotherapy-chemo combo shows promise
Disease control Recruiting nowThis study tests whether adding pembrolizumab (an immunotherapy) to a gentler chemotherapy mix can safely treat frail patients newly diagnosed with classical Hodgkin lymphoma who cannot handle standard strong chemo. About 23 participants will receive the combination and be monito…
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 02, 2026 11:40 UTC
-
Can a simple blood test predict heart trouble in childhood cancer survivors?
Knowledge-focused Recruiting nowThis study looks at how certain blood cell changes (called clonal hematopoiesis) after Hodgkin lymphoma treatment might be linked to later heart problems. Researchers will test blood samples from 190 survivors who received chemotherapy as children or young adults. The goal is to …
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:55 UTC
-
Immunotherapy may weaken bones: new study investigates hidden risk
Knowledge-focused Recruiting nowThis study looks at whether immunotherapy drugs (anti-PD-1) can weaken bones and increase fracture risk in people being treated for cancer. About 25 adults with various cancers will have their bone density and blood markers measured over a year. The goal is to gather information …
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: NA • Sponsor: Jessica Mezzanotte Sharpe • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:04 UTC